This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

97 Resources
97 Resources
97 Resources
    Date
  1. This document describes the methods and procedures that were determined to provide the optimal results. The methods and procedures described in this document have been utilized by PATH and other researchers with favorable results that correlate well with ELISA results and/or microfilaria staus. The goal of this document is to broadly disseminate these methods and procedures as best practices for utilizing DBS specimens with the rapid tests to the onchocerciasis community.
    Published: June 2019
    Type: Resource Page
  2. The new, four-year Devices, Diagnostics, and Drugs to Address Women’s Needs Product Development Partnership (D3AWN PDP) is tapping into PATH’s deep PDP expertise to develop and introduce a portfolio of devices, diagnostics, and drugs to prevent or manage preeclampsia/eclampsia (PE/E) and PPH. The D3AWN PDP is advancing affordable, accessible, safe, and effective tools for sub-Saharan communities. Solutions include:Heat-stable FDT for PPH prevention: Sublingual oxytocin in heat-stable, fast dissolving tablet.Reusable, electricity-free infusion pump for the delivery of lifesaving nutrients, fluids, and medicines: RELI Delivery System.Uterine balloon tamponade for the management of PPH: Sinapi Ellavi Uterine Balloon Tamponade.Urinary dipstick test for improved diagnoses of PE/E: LifeAssay Diagnostics Test-it™ PrCr Urinalysis Dipstick Test
    Published: June 2019
    Type: Resource Page
  3. The G6PD Operations Research Community of Practice (GORCoP) is a collaboration of researchers, organizations, and clinicians committed to advancing the introduction and scale-up of glucose-6-phosphate dehydrogenase (G6PD) diagnostics in support of safe access to radical cure treatment for Plasmodium vivax malaria through operations research. There are several G6PD diagnostics available now and in the pipeline that have the potential to expand access to safe radical cure. The GORCoP seeks to understand the transitions that health systems will need to undergo and to inform best practices for undergoing these transitions.
    Published: May 2019
    Type: Resource Page
  4. This set of three user personas was developed to inform the design and development of next generation HIV self-tests. Originally developed for use by health workers, rapid HIV tests have expanded to include the self-testing use case. Individuals testing themselves have different needs and motivations than health workers, and these attributes can be captured clearly through user personas.Personas are a methodological tool used in user-centered design to understand user needs. They represent the characteristics and goals of a user group, including common behaviors, skills, attitudes, limitations, and constraints. Personas also capture information on the environment in which the user group operates. The purpose of personas is to communicate user needs and build a common understanding within multidisciplinary teams that can provide focus throughout the product development process, from defining functional product requirements to designing effective delivery strategies.The three personas selected represent key populations of interest to global and national stakeholders working on HIV/AIDS. These personas were developed in a two-phase process. First, draft personas were created based on literature reviews and expert interviews (n=3). The draft personas were then refined using in-person, semi-structured interviews with members of the user group (n=25-40) to generate validated personas. PATH has conducted and championed “right-fit” technology development since its founding 40 years ago, recognizing that aligning with the motivations and constraints of the end user is essential for product uptake and, ultimately, the ability of a new tool to improve health outcomes.
    Published: December 2018
    Type: Resource Page
  5. Environmental enteric dysfunction (EED) is an intestinal disorder common among children living in low-resource settings. EED is associated with increased risk of growth stunting, cognitive deficits, and reduced responsiveness to oral vaccines. This resource provides an overview of PATH's work to develop a prototype assay to quantitate multiple markers of EED, systemic inflammation, growth hormone (GH) resistance, and micronutrients for use in EED clinical research in low-resource settings.
    Published: November 2018
    Type: Resource Page
Load more